D-0758-2026 Class III Ongoing
FDA drug recall D-0758-2026 was initiated by Supernus Pharmaceuticals, Inc. on Jul 6, 2026 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 15,853 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 29, 2026
- Initiation Date
- Jul 6, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,853 bottles
Product description
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Reason for recall
Failed Dissolution Specifications
Distribution pattern
US Nationwide.
Code information
Lot # 2075801, Exp Date: 31-Oct-2029.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0758-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026